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2: Problem Identification


In 2014 and 2015 the Vermont Department of Health reported that ‘the vast majority of Vermonters
are immunized’ yet ‘a small numbers of adults and children’ remain.




The 2013 Vermont Immunization Program Annual Report indicated that Vermont was below national and state goals in
toddler immunization (63% Vermont, 68% nat. average, 80% 2020 Healthy People Goal), was average in teen vaccination,
and was above state average in zoster vaccination and male HPV vaccination. Data regarding PPSV23 immunization was not
included.

A 2015 survey of naturopathic providers in Vermont indicated that a substantial portion of their
patient population feels they have specific concerns and fears around vaccinations that have not been
adequately heard or addressed by other providers which lead them to choose not to vaccinate or to
pursue alternative vaccination schedules.


This suggests there are likely sub-populations of interest which are not adequately represented by aggregate vaccination
data, who may be good targets for target discussion and distribution of specific vaccination information material.



According to the WHO the incidence of measles, mumps, and pertussis in the United States grew
from 43, 800, and 10,454 in 2007 to 667, 1,223, and 32,971 in 2014 respectively.



In 2015 Vermont eliminated the philosophical exemption, purchased $13 million in pediatric
vaccines for use in primary care offices, expanded the HPV Vaccine Initiative group to provide HPV
vaccinations, and drove the “It’s OK to Ask” campaign to encourage vaccination discourse.
Unprecedented levels of state support and public awareness make it an opportune time to identify
and eliminate barriers to vaccination at the community level through primary care provider offices.

3: Public Health Cost






HealthyPeople.gov and the CDC rank
vaccines as among the most cost-effective
preventative health service.
The Office of Disease Prevention and
Healthy Promotion estimates that
vaccination of each yearly birth cohort to
CDC recommendations reduces health
care costs by $9.9 billion and saves $33.4
billion in indirect costs.
The CDC estimates the per cost of each of
the most common vaccine preventable
illness hospitalizations to be as shown in
table 1.


In 2013 there were 9/100,000 cases of pertussis
in the United States, the highest since the 1950’s.

Table 1

Disease

Average Cost Per
Hospitalization

Diphtheria

$16.9K

Tetanus

$102.5K

Pertussis

$10.7K

Measles

$4.0K

Mumps

$11.1K

Rubella

$4.8K

Varicella

$4.1K

Pneumococcal

$3.1K

4: Community Perspective
Dr. Clara Keegan

Dr. Aaron Reiter

What are the most important influences on patient decisions to vaccinate
Towards not vaccinating:
• Cost
• Personal experience with adverse effects
• Trust/distrust of “Big Pharma”

Provider recommendation
Personal experience with adverse effects
Trust/Distrust of “Big Pharma”
Cultural background

Toward vaccinating:
• Provider recommendation
• Trust/Distrust of government recommendations
• Cultural Background

Are you able to fully address these concerns during OV’s?
Generally. Most difficult: “I don’t know about additives in
different vaccines.”

Some, although some are accurate (Rotavirus).

What percent of your patients would you say are fully/partially vaccinated?
51-75% (fully)
76+% (at least partially)

76+% (both)

5: Intervention and Methodology
Goal

1.
1.

To analyze compliance with CDC vaccination guidelines in order
to identify vaccinations of concern to patients served by the South
Burlington FM practice and help address specific issues related to
those vaccinations.

Methodology

2.
1.

Over 4 weeks vaccination compliance with CDC guidelines for
MMR, Tetanus, Diptheria, Pertussis, Influenza, pneumonia
(PPSV23/13)*, HPV, and Zoster* was assessed at each annual
physical. No identifying data was recorded.
*when indicated

Intervention

3.
1.

Develop prepared reference material to which can be included as
an after-visit summary smart-phrase and/or waiting area
pamphlet which helps address the most common patient
concerns.

6a: Results/Response
43 annual wellness visits/physicals between July
18 and Aug 9 were assessed. 2 were excluded from
analysis based on pending immunization history.

1.





30/41 (73.1%) were fully vaccinated to CDC
recommendations.
11 (26.8%) did not meet CDC recommendations.
4 visits were adults >40 years of age, who did not meet Tetanus
and Pertussis vaccination recommendations.
 2 visits were cases that did not meet PPSV23 vaccination
recommendations.
 5 visits were cases that did not meet Zoster vaccination
recommendations.


6b: Results/Response: Zoster Vaccination
 Retrospective meta-review of all patients seen at SBFP in the

previous 30 days was performed in using bulk queries in Epic
EMR to review Zoster vaccination statistics. No individual
identifying data was stored or used for analysis.




438/1006 (43.5%) patients >60yo did not meet zoster vaccination standards.
105/289 (36.3%) patients between 60-64yo and eligible for free Zoster coverage
did not meet recommendations.
73/228 patients between 61-64yo had had a previous annual visit and did not
meet recommendations, indicating they did not vaccinate at age 60.

 Compared to the state average of ~47% Shingles vaccination,

these data suggest that compliance amongst the SBFP clinic is
quite good. However, a substantial portion of patients who
would benefit from the vaccine remain unvaccinated despite no
cost.

7: Effectiveness and Limitations
Effectiveness

1.
1.

Assessing the effectiveness of this project can be done by repeating requerying the data for vaccination rates at 1 year intervals while keeping the
sample set and comparing it against both the data here, and against a new
incoming one.

Limitations

2.
1.

2.

Improving vaccination rates by addressing patient fears and concerns is
critical to the continued improvement of community health at the population
level. While it is fortunate that there is a very high degree of vaccination
compliance at SBFM, it suggests that demographics choosing not to vaccinate
or to vaccinate incompletely may not be well represented at SBFM. Engaging
this population may require an approach outside the scope of the family
medicine primary care office setting.
This study was also limited by the scope of aggregate data access available
through Epic. Only patients in the last 30 days were able to used in the
dataset, and the scripting with which to analyze and sort information in the
dataset was limited to basic queries and filters.

8: Future Follow-up
1.

Adults between the 60-64 years of age at SBFP are not limited from
vaccination by a cost barrier. In addition, provider interviews at SBFP and
in a 2015 study regarding Naturopathic providers both suggest that the most
important factor on patient decisions to vaccinate are provider opinions and
influence. Direct interviews with this population are not possible at the
moment due to IRB approval requirements, but would be helpful towards
identifying additional barriers to vaccination in the future.
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